Biochemical assessment of the nutritional status of cystic fibrosis patients treated with pancreatic enzyme extracts

American Journal of Clinical Nutrition

Volumn 67, Issue 5, 1998, Pages 912-918

  Benabdeslam, Hassiba ^a   Garcia, Isabelle ^a   Bellon, Gabriel ^a   Gilly, Robert ^a   Revol, André ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Albumin; Cystic fibrosis; Fat nutritional state; Fatty acid; Malabsorption; Malnutrition; Pancreatic extracts; Protein status; Retinol; tocopherol

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; APOLIPOPROTEIN A1; ARACHIDONIC ACID; BIOCHEMICAL MARKER; CHOLESTEROL; CHOLESTEROL ESTER; ESSENTIAL FATTY ACID; KREON; LINOLEIC ACID; LIPOPROTEIN; PANCREAS EXTRACT; PANCRELIPASE; PHOSPHOLIPID; RETINOL; RETINOL BINDING PROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; ENZYME REPLACEMENT; FEMALE; HUMAN; LIPID COMPOSITION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PROTEIN MALNUTRITION; VITAMIN INTAKE;

EID: 0031968801     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/67.5.912     Document Type: Article

References (55)

1. Reardon MC, Hammond KB, Accurso FJ, et al. Nutritional deficits exist before 2 months of age in some infants with cystic fibrosis identified by screening test. J Pediatr 1984;105:271-4.
2. Marcus MS, Sondel SA, Farrell PM, et al. Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention. Am J Clin Nutr 1991;54:578-85.
3. Mearns MB. Cystic fibrosis. Arch Dis Child 1985;60:272-7.
4. Neijens HJ, Duiverman EJ, Kerrebijn KF, Sinaasappel M. Influence of respiratory exacerbations on lung function variables and nutritional status in CF patients. Acta Paediatr Scand Suppl 1985;317:38-41.
5. Winklhofer-Roob BM. Oxygen free radicals and antioxidants in cystic fibrosis: the concept of an oxidant-antioxidant imbalance. Acta Peadiatr 1994;395(suppl):49-57.
6. Dodge JA. Gastrointestinal tract and nutrition in cystic fibrosis: pathophysiology. J R Soc Med 1986;12(suppl):27-31.
7. Gaskin KJ. The impact of nutrition in cystic fibrosis: a review. J Pediatr Gastroenterol Nutr 1988;7(suppl):S12-7.
8. George DE, Mangos JA. Nutritional management and pancreatic enzyme therapy in cystic fibrosis patients: state of the art in 1987 and projections into future. J Pediatr Gastroenterol Nutr 1988;7(suppl):S49-57.
9. Heymans HSA. Gastrointestinal dysfunction and its effects on nutrition in CF. Acta Paediatr Scand Suppl 1989;363:74-9.
10. Bouquet J, Sinaasapel M, Neijens HJ. Malabsorption in cystic fibrosis: mechanisms and treatment. J Pediatr Gastroenterol Nutr 1988;7(suppl):S30-5.
11. Daniels LA, Davidson GP. Current issues in the nutritional management of children with cystic fibrosis. Aust Paediatr J 1989;25:261-6.
12. Taylor CJ. The problems with high dose pancreatic enzyme preparations. Drug Saf 1994;11:75-9.
13. National Research Council. Recommended dietary allowances. 10th ed. Washington, DC: National Academy Press, 1989.
14. Shwachman H, Kulczycki LL. Long-term study of one hundred five patients with cystic fibrosis. Am J Dis Child 1958;96:6-15.
15. Brasfield D, Hicks G, Soong SJ, Peters J, Tiller R. The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics 1979;63:24-9.
16. Whicher JT, Ritchie RF, Johnson AM, et al. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 1994;40:934-8.
17. Haan GJ, Van Der Hiede S, Wolthers BG. Analysis of fatty acids from human lipids by gas chromatography. J Chromatogr 1979;162:261-71.
18. Ohta A, Mayo MC, Kramer N, Lands WEM. Rapid analysis of fatty acids in plasma lipids. Lipids 1990;25:742-7.
19. Catignani GL, Bieri JG. Simultaneous determination of retinol and α-tocopherol in serum or plasma by liquid chromatography. Clin Chem 1983;29:708-12.
20. Holman RT. The ratio of trienoic:tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. J Nutr 1960;70:405-10.
21. Sinaasappel M, Bouquet J, Neijens HJ. Problems in the treatment of malabsorption in CF. Acta Paediatr Scand Suppl 1985;317:23-7.
22. Fernandes J, Kneepkens CMF, Bijleveld CMA, Vonk RJ. General aspects of nutrition, absorption and metabolism in patients with cystic fibrosis. Acta Paediatr Scand Suppl 1985;317:5-8.
23. Weber AM, Roy CC, Chartrand L, et al. Relationship between bile acid malabsorption and pancreatic insufficiency in cystic fibrosis. Gut 1976;17:295-9.
24. Colombo C, Roda A, Roda E, et al. Bile acid malabsorption in cystic fibrosis with and without pancreatic insufficiency. J Pediatr Gastroenterol Nutr 1984;3:556-62.
25. Williams SGJ, Westaby D, Tanner MS, Mowat AP. Liver and biliary problems in cystic fibrosis. Br Med Bull 1992;48:877-92.
26. Penny DJ, Ingall CB, Boulton P, Walker-Smith JA, Basheer SM. Intestinal malabsorption in cystic fibrosis. Arch Dis Child 1986;61:1127-8.
27. Hughes RL, Sahgal V, Craig R. Potential effects of nutritional state on pulmonary function in cystic fibrosis. Acta Paediatr Scand Suppl 1985;317:42-7.
28. Blomhoff R, Green MH, Berg T, Norum KR. Transport and storage of vitamin A. Science 1990;25:399-404.
29. Littlewood JM, MacDonald A. Rationale of modern dietary recommendations in cystic fibrosis. J R Soc Med 1987;80(suppl 15):16-24.
30. Smerling DH, Forrer JCW, Prader A. Faecal fat and nitrogen in healthy children and in children with malabsorption or maldigestion. Pediatrics 1970;46:690-5.
31. Hendricks KM, Duggan C, Gallagher L, et al. Malnutrition in hospitalized pediatric patients. Arch Pediatr Adolesc Med 1995;149:1118-22.
32. Portal B, Richard MJ, Faure HS, Hadjian A, Favier A. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1995;61:843-7.
33. Vaughan WJ, Lindgren FT, Whalen JB, Abraham S. Serum lipoprotein concentrations in cystic fibrosis. Science 1978;199:783-6.
34. Weber AM, Roy C, Morin CL, Lasalle R. Malabsorption of bile acids in children with cystic fibrosis. N Engl J Med 1973;289:1001-5.
35. Levy E, Lepage G, Bendayan M, et al. Relationship of decreased hepatic lipase and lipoprotein abnormalities to essential fatty acid deficiency in cystic fibrosis. J Lipid Res 1989;30:1197-209.
36. James DR, Alfaham M, Goodchild MC. Increased susceptibility to peroxide-induced haemolysis with normal vitamin E concentrations in cystic fibrosis. Clin Chim Acta 1991;204:279-90.
37. Chase HP, Dupont J. Abnormal levels of prostaglandins and fatty acids in blood of children with cystic fibrosis. Lancet 1978;2:236-8.
38. Farrell PM, Mischler EH, Engle MJ, Brown DJ, Lau SM. Fatty acid abnormalities in cystic fibrosis. Pediatr Res 1985;19:104-9.
39. Rogiers V, Vercruysse A, Dab I, Baran D. Abnormal fatty acid pattern of the plasma cholesterol ester fraction in cystic fibrosis patients with and without pancreatic insufficiency. Eur J Pediatr 1983;141:39-42.
40. Lloyd-Still JD, Johnson SB, Holman RT. Essential fatty acid status and fluidity of plasma phospholipids in cystic fibrosis infants. Am J Clin Nutr 1991;54:1029-35.
41. Hubbard VS, Dewey Dunn G, Di Sant'Agnese PA. Abnormal fatty-acid composition of plasma lipids in cystic fibrosis - a primary or secondary defect? Lancet 1977;2:1302-4.
42. Galabert C, Filliat M, Chazalette JP. Fatty acid composition of serum lecithins in cystic fibrosis patients without steatorrhoae. Lancet 1978;2:903 (abstr).
43. Rivers JPW, Hassam AG. Defective essential fatty acid metabolism in cystic fibrosis. Lancet 1975;2:642-3.
44. Craig-Schmidt MC, Faircloth SA, Teer PA, Weete J, Wu CY. The essential fatty acid deficient chicken as a model for cystic fibrosis. Am J Clin Nutr 1986;44:816-24.
45. Parsons HG, O'Loughlin, Forbes D, Cooper D, Gall G. Supplemental calories improve essential fatty acid deficiency in cystic fibrosis patients. Pediatr Res 1988;24:353-6.
46. Lepage G, Kneepkens CMF, Roy CC. Peroxysomal dysfunction associated with essential fatty acids deficiency. Med Sci 1993;9:571-6 (in French).
47. Harper TB, Chase HP, Henson J, Henson PM. Essential fatty acid deficiency in the rabbit as a model of nutritional impairment in cystic fibrosis. In vitro and in vivo effects on lung defense mechanisms. Am Rev Respir Dis 1982;125:540-7.
48. Farell PM, Bieri JG, Fratantoni JF, Wood RE, Di Sant'Agnese PA. The occurrence and effects of human vitamin E deficiency: a study in patients with cystic fibrosis. J Clin Invest 1977;60:233-41.
49. Underwood BA, Denning CR. Blood and liver concentrations of vitamins A and E in children with cystic fibrosis of the pancreas. Pediatr Res 1972;6:26-31.
50. Congden PJ, Bruce G, Rothburn MM, et al. Vitamin status in treated patients with cystic fibrosis. Arch Dis Child 1981;56:708-14.
51. Sokol RJ, Reardon MC, Accurso FJ, et al. Fat-soluble-vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns. Am J Clin Nutr 1989;50:1064-71.
52. Ahmed F, Ellis J, Murphy J, Wootton S, Jackson AA. Excessive faecal losses of vitamin A (retinol) in cystic fibrosis. Arch Dis Child 1990;65:589-93.
53. Smith FR, Underwood BA, Denning CR, Varma A, Goodmen W. Depressed plasma retinol binding protein levels in cystic fibrosis. J Lab Clin Med 1972;80:423-33.
54. Winklhofer-Roob BM, Shmerling DH, Schimerk MG, Tuchschmid PE. Significance of dl-α-tocopherol acetate supplementation in patients with cystic fibrosis. Pediatr Res 1990;28:283 (abstr).
55. Winklhofer-Roob BM, Van't Hof MA, Shmerling DH. Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-α-tocopherol compared with all-rac-α-tocopheryl acetate preparations. Am J Clin Nutr 1996;63:722-8.